AHA: AR Flashcards
class 3 recommendation(s) for AVI choice (TAVI v SAVR) in isolated severe AR
NOT TAVI
(3: HARM)
assuming SAVR candidate
“7. In patients with isolated severe AR who have indications for SAVR and are candidates for surgery, TAVI should not be performed.”
regurgitant jet width (% of LVOT) in mild AR
<25
%
vena contracta in mild AR
<0.3
cm
RVol/Vregurg in mild AR
regurgitant volume
<30
mL/beat
RF in mild AR
regurgitant fraction
<30
%
EROA in mild AR
effective regurgitant orifice area
<0.1
cm2
grade in mild AR
1+
prox abd Ao/desc Ao flow reversal in mild AR
AHA: prox abd / ASE: desc Ao
brief, early
only specified in ASE
AHA does not mention for mild/mod; ASE does not mention for mod
regurgitant jet width (% of LVOT) in moderate AR
25-65
%
vena contracta in moderate AR
0.3-0.6
cm
RVol/Vregurg in moderate AR
regurgitant volume
30-60
mL/beat
RF in moderate AR
regurgitant fraction
30-50
%
EROA in moderate AR
effective regurgitant orifice area
0.1-0.3
cm2
grade in moderate AR
2+
prox abd Ao/desc Ao flow reversal in moderate AR
AHA: prox abd / ASE: desc Ao
N/A
AHA does not mention for mild/mod; ASE does not mention for mod
regurgitant jet width (% of LVOT) in severe AR
≥65
%
vena contracta in severe AR
>0.6
cm
RVol/Vregurg in severe AR
regurgitant volume
≥60
mL/beat
RF in severe AR
regurgitant fraction
≥50
%
EROA in severe AR
effective regurgitant orifice area
≥0.3
cm2
grade in severe AR
3-4+
prox abd Ao/desc Ao flow reversal in severe AR
AHA: prox abd / ASE: desc Ao
holodiastolic
AHA does not mention for mild/mod; ASE does not mention for mod
aortic valve
regurgitant jet width (% of LVOT) <25 %
mild AR
aortic valve
vena contracta <0.3 cm
mild AR
aortic valve
RVol/Vregurg <30 mL/beat
regurgitant volume
mild AR
aortic valve
RF <30 %
regurgitant fraction
mild AR
aortic valve
EROA <0.1 cm2
effective regurgitant orifice area
mild AR
aortic valve
1+ grade regurg
mild AR
aortic valve
regurgitant jet width (% of LVOT) = 25-65 %
moderate AR
aortic valve
vena contracta = 0.3-0.6 cm
moderate AR
aortic valve
RVol/Vregurg = 30-60 mL/beat
regurgitant volume
moderate AR
aortic valve
RF = 30-50 %
regurgitant fraction
moderate AR
aortic valve
EROA = 0.1-0.3 cm2
effective regurgitant orifice area
moderate AR
aortic valve
2+ grade regurg
moderate AR
aortic valve
regurgitant jet width (% of LVOT) ≥65 %
severe AR
aortic valve
vena contracta >0.6 cm
severe AR
aortic valve
RVol/Vregurg ≥60 mL/beat
regurgitant volume
severe AR
aortic valve
RF ≥50 %
regurgitant fraction
severe AR
aortic valve
EROA ≥0.3 cm2
effective regurgitant orifice area
severe AR
aortic valve
3-4+ grade regurg
severe AR
Is degenerative or rheumatic AR more common?
neither
~50/50
indication(s) for intervention in moderate AR
- concomitant <3 surg (2a)
regardless of sx status
“In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.”
indication(s) for intervention in moderate AR
(1)
- concomitant <3 surg (2a)
regardless of sx status
“In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.”
indication(s) for intervention in asx moderate AR
- concomitant <3 surg (2a)
regardless of sx status
“In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.”
indication(s) for intervention in sx moderate AR
- concomitant <3 surg (2a)
regardless of sx status
“In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.”
indication(s) for intervention in sx severe AR
YES
severe + sx = indicated
(1)
regardless of EF
“1. In symptomatic patients with severe AR (Stage
D), aortic valve surgery is indicated regardless
of LV systolic function.” (1)
indication(s) for intervention in sx severe AR
(1)
YES
severe + sx = indicated
(1)
regardless of EF
“1. In symptomatic patients with severe AR (Stage
D), aortic valve surgery is indicated regardless
of LV systolic function.” (1)
indication(s) for intervention in asx severe AR
- EF≤55% if no other cause identified (1)
- concomitant <3 surg (1)
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
OR if low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
mgmt of asx severe AR + EF=55%
AVR
- EF≤55% if no other cause identified (1)
mgmt of asx severe AR + concomitant <3 surg
AVR
- concomitant <3 surg (1)
mgmt of asx severe AR + EF=65% + LVESD=55mm
AVR
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
indication(s) for intervention in asx severe AR
(5)
- EF≤55% if no other cause identified (1)
- concomitant <3 surg (1)
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
OR if low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
class 1 indication(s) for intervention in asx severe AR
(2)
- EF≤55% if no other cause identified (1)
- concomitant <3 surg (1)
class 2 indication(s) for intervention in asx severe AR
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
OR if low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
class 1 indication(s) for intervention in asx severe AR
- EF≤55% if no other cause identified (1)
- concomitant <3 surg (1)
class 2 indication(s) for intervention in asx severe AR
(3)
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
OR if low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
class 2b indication(s) for intervention in asx severe AR
low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
class 2a indication(s) for intervention in asx severe AR
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
class 2a indication(s) for intervention in asx severe AR
(1)
- EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
class 2b indication(s) for intervention in asx severe AR
(2)
low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
indication(s) for intervention in severe AR
- sx (1)
- asx + EF≤55% if no other cause identified (1)
- concomitant <3 surg (1)
regardless of sx status - asx + EF>55% BUT LVESD>50mm / 25mm/m2 (2a)
OR asx + low-risk AND EF>55%:
- BUT progressive ↓ EF on 3 studies to 55-60% (2b)
- BUT progressive ↑ LVEDD on 3 studies to >65mm (2b)
LVESD threshold for intervention on severe AR
> 50mm / 25mm/m2
(in asx with EF>55%)
LVEDD threshold for intervention on severe AR
>65mm
(progressive on 3 studies
in asx + low-risk AND EF>55%)
ONLY indication for intervention in moderate AR
- concomitant <3 surg (2a)
regardless of sx status
class 3 recommendation for severe AR intervention
NOT TAVI
(3: HARM)
assuming SAVR candidate
“7. In patients with isolated severe AR who have indications for SAVR and are candidates for surgery, TAVI should not be performed.”